Neurogenic Orthostatic Hypotension (NOH) is a surprisingly common condition where people become lightheaded when they stand up, with high risk for falls and injury. Few options exist for treatment, so there is need for new approaches.
| Condition(s) | Type of Drug | Phase | Placebo | Duration | Open Label Extension |
|---|---|---|---|---|---|
| NOH | Droxidopa (approved) | IV | 25% | 24 weeks | 24 weeks |
If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-8899 or use the form below. One of our skilled Clinical Research Coordinators will contact you as soon as possible. Thank you for your interest in our research!